ARTICLE
|
doi:10.20944/preprints202207.0371.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
biosymilars; metastatic breast cancer; trastuzumab; cost; her2; PTH
Online: 25 July 2022 (10:05:29 CEST)
ARTICLE
|
doi:10.20944/preprints202201.0164.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
breast cancer,; neoadjuvant chemotherapy; elederly; HER2- positive; pathological complete response; safety
Online: 12 January 2022 (13:31:16 CET)